Epizyme Inc
NASDAQ:EPZM 3:59:50 PM EDT
Earnings Announcements
Epizyme Reports First Quarter 2022 Financial Results And Provides Business Update
Published: 05/10/2022 11:37 GMT
Epizyme Inc (EPZM) - Epizyme Reports First Quarter 2022 Financial Results and Provides Business Update.
Q1 Loss per Share $0.38.
Q1 Revenue Rose 14 Percent to $8.7 Million.
Cash, Cash Equivalents and Marketable Securities Were $199.7 Million As of March 31, 2022.
Q1 Earnings per Share View $-0.35, Revenue View $10.4 Million -- Refinitiv Ibes Data (analyst estimates).
Q1 Loss per Share $0.38.
Q1 Revenue Rose 14 Percent to $8.7 Million.
Cash, Cash Equivalents and Marketable Securities Were $199.7 Million As of March 31, 2022.
Q1 Earnings per Share View $-0.35, Revenue View $10.4 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $10.21 Million
Adjusted EPS is expected to be -$0.34
Next Quarter Revenue Guidance is expected to be $11.94 Million
Next Quarter EPS Guidance is expected to be -$0.30
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.34
Next Quarter Revenue Guidance is expected to be $11.94 Million
Next Quarter EPS Guidance is expected to be -$0.30
More details on our Analysts Page.